Table 1.
Demographics and comorbidities.
| AD | Delirium | Controls | Significance | |
|---|---|---|---|---|
| N | 33 | 16 | 22 | |
| Age | 76 (73–79) | 79.5 (74–87) | 73 (64–79) | 0.0759 (Kruskal–Wallis) |
| Median (95% CI) | ||||
| Sex | 14/19 | 9/7 | 14/8 | 0.281 (Fisher) |
| M/F | ||||
| Premorbid comorbidities | ||||
| Neurologic | 31 (94%) | 16 (100%) | 19 (86%) | 0.256 (Fisher) |
| Cortical atrophy | 28 (85%) | 12 (75%) | 4 (18%) | <0.001* (Fisher) |
| Microangiopathy | 22 (67%) | 14 (88%) | 8 (36%) | 0.004* (Fisher) |
| Pre-described dementia | 4 (12%) | 8 (50%) | 0 (0%) | <0.001* (Fisher) |
| PNP | 3 (10%) | 4 (25%) | 12 (54%) | <0.001* (Fisher) |
| Chronic stroke | 5 (15%) | 5 (31%) | 1 (5%) | 0.080 (Fisher) |
| Systemic infections | 3 (9%) | 7 (44%) | 3 (14%) | 0.017* (Fisher) |
| Cardiac | 24 (73%) | 14 (88%) | 13 (59%) | 0.153 (Fisher) |
| Pulmonary | 3 (9%) | 1 (6%) | 3 (14%) | 0.773 (Fisher) |
| Metabolic | 17 (52%) | 9 (56%) | 7 (32%) | 0.266 (Fisher) |
| Oncologic | 12 (36%) | 3 (19%) | 3 (14%) | 0.144 (Fisher) |
| Musculoskeletal | 9 (27%) | 7 (44%) | 10 (45%) | 0.331 (Fisher) |
| Others | 13 (39%) | 8 (50%) | 9 (41%) | 0.780 (Fisher) |
*p < 0.05.